Prevalence of Intestinal Helminths among Cancer Patients Who Are under Chemotherapy at the University of Gondar Comprehensive Specialized Hospital Oncology Clinic, Northwest Ethiopia

Sitotaw, Elsa; Sitotaw, Adino; Aleka, Yetemwork; Lemma, Mulualem

doi:https://doi.org/10.1155/2022/4484183

Journal of Cancer Epidemiology

On this page

Abstract Introduction Methods and Materials Discussion Conclusions Abbreviations Data Availability Conflicts of Interest Authors’ Contributions Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2022 | Article ID 4484183 | https://doi.org/10.1155/2022/4484183

Prevalence of Intestinal Helminths among Cancer Patients Who Are under Chemotherapy at the University of Gondar Comprehensive Specialized Hospital Oncology Clinic, Northwest Ethiopia

Elsa Sitotaw,¹Adino Sitotaw,²Yetemwork Aleka,¹and Mulualem Lemma¹

Academic Editor: Arjun Singh

Received03 Dec 2021

Revised10 Mar 2022

Accepted23 Mar 2022

Published18 Apr 2022

Abstract

Background. In developing countries, environmental and personal hygiene is playing a great role in the increasing of intestinal helminth infection. In countries with limited resources and poor hygiene practices, there is a substantial overlap of intestinal helminthic and chronic infections like HIV, TB, and cancer. Intestinal helminths like Ascaris lumbricoides, Trichuris trichiura, and hookworm cause malnutrition and induce a type-2 immune response that could worsen the severity and clinical outcomes of patients with cancer. Our aim was to determine the prevalence of intestinal helminths among cancer patients who are under chemotherapy. Methodology. A prospective cross-sectional study was conducted in volunteer cancer patients. Clinical information were collected from study participants using a structured questioner. Stool sample was collected for parasitological examination. Formol-ether concentration technique was done, and then, two microscopic slides were prepared. Examination was done by two laboratory technicians for the detection of helminths. SPSS version 22 was used for data analysis, and simple descriptive statistical analysis was done for data presentation. Result. The total study participants were 41, of these 31 (75.6%) were females and 10 (24.4%) were male. Breast cancer and colonic cancer were the highest proportion with the others, 43.9% and 17.1%, respectively. The prevalence of intestinal parasites were 7/41 (17%). Hookworm 3/41(7.3%), Ascaris lumbricoides 3/41(7.3%), and Hymenolepis nana 1/41(2.4%) are the isolated parasite. Conclusions and Recommendations. The prevalence of intestinal helminths in cancer is lower than HIV and DM in the study area. However, the prevalence in these cancer patients is still high and needs deworming and health education for the better management of these cancer patients.

1. Introduction

Environmental and personal hygiene is very fundamental for the community as well as for the people who need special attention, since it has a great impact on the global disease burden. Low-income countries of Asia and Africa are with in high risk of environmental factors. These risk factors cause illness and death from helminth infection, respiratory infection, and diarrhea [1].

In the world, more than 1.5 billion people are infected by soil-transmitted helminths. From all these helminthes, the most common are roundworm (Ascaris lumbricoides), the whipworm (Trichuris trichiura), and hookworms (Necator americanus and Ancylostoma duodenale) [2]. Like helminths, cancer is also the major cause of mortality and morbidity in the globe, so it caused 19.3 million new cases and 10 million deaths in 2020 [3].

Intestinal helminthes have an impact on individuals by competing with micronutrients, which is very vital for the general physiology and immune response [4, 5]. On the other hand, most helminthes induce type-2 immune responses, which will downregulate the type-1 immune responses which have a pivotal role for the protection of cancer, HIV, and other infections [6].

Today, cancer is one of the big challenges of mankind, and among the 100 types of cancer, lung, stomach, liver, colon, and breast are the most fatal in each year [7]. In cancer patients under chemotherapy, their immune system is usually compromised through the disease itself and the chemotherapy they take [8]. When cancer patients under chemotherapy coinfected with helminths, their protective immune response will be highly compromised as the helminth-induced type-2 immune response could further counteract the type-1 immune response. Therefore, helminth coinfection in cancer patients will worsen the patient’s condition, and that both opportunistic and nonopportunistic parasite infections become highly pathogenic. This consequence can increase the morbidity and the mortality rate of cancer patients [9, 10].

Even if certain studies have been investigating the prevalence of intestinal parasites in the community and in immune compromised patients like HIV and TB [11–13] in our country, there is no any study done on cancer patients in our setting where helminth infections are highly prevalent. Therefore, our study was aimed at evaluating the prevalence of intestinal helminthes in cancer patients under chemotherapy follow-up in University of Gondar Comprehensive Specialized Hospital, in northwest Ethiopia.

2. Methods and Materials

2.1. Study Design

Institutional based prospective cross-sectional study was conducted from February 2020 to May 2020. From cancer, these patients are under chemotherapy.

2.2. Study Subjects

We randomly selected 50 study participants from the outpatient unity of oncology clinic who were willing to participate in our study at University of Gondar Comprehensive Specialized Hospital. All study participants were in different stages of cancer with different cycles of chemotherapy. From these, 9 refused to give stool samples and were excluded from the study.

2.3. Data Collection

Independent variables and other clinical variables were collected directly from the patients and their medical record sheets by using a structured questionnaire.

2.4. Laboratory Methods

Stool sample was collected from the study participants and preserved by using 10% formaldehyde. Direct wet mount examination and formol-ether concentration technique were done to concentrate the helminths. Two slides from each technique were prepared for the screening of helminths by two laboratory technologists.

2.5. Data Entry and Analysis

All sociodemographic and clinical data and laboratory findings were entered into the SPSS version 22, and simple descriptive analysis was done.

2.6. Ethical Considerations

Ethical clearance was obtained from the Research and Ethics committee of School of Biomedical and Laboratory Science, College of Medicine and Health Science, University of Gondar. The participants were included after we obtained written informed consent. All personal information and identifiers of the study participants were kept conditionally, and those who were positive for any intestinal helminthes were treated with antihelminthic drugs.

3. Result

In our study, 31 (75.6%) participants were females, and the age groups of 29-39 and 40-50 both have 14% of the portion of the study participants. The residents of the study participants are urban 21 (51.2%) and rural 20 (48.8%) (Table 1). Breast cancer (43.9%) and colonic cancer (17.1%) were the highest proportions of the total study participants (Table 2).

From these cancer patients, their cancer stages at three were the height’s proportion (20 (48.7%)) and from the total study participants. 17 (41.2%) of them had a hemoglobin level ≤12g/dl (Table 3). The overall intestinal helminth prevalence was 7/41 (17%). These helminths were hookworm, Ascaris lumbricoides, and Hymenolepis nana, which had the prevalence of 3/41(7.3%), 3/41(7.3%), and 1/41(2.4%), respectively (Table 4).

4. Discussion

Helminthes are the most common infectious agent of mankind and widespread in developing countries. It has been known that the morbidity of malaria, HIV, and impaired vaccine efficacy are more enhanced in Africa [14]. One of the main factors for the high burden of these morbidities in the continent is due to the high coprevalence of intestinal helminths. This might be due to the disturbance and impairment of the nutritional status of the host as a result of helminthic infections. It has been evidenced that the chronic form of intestinal helminthes with high parasitic load could reduce the absorption of vitamin A and other micronutrients (zinc, folate, and vitamin B-12) [15–17].

Moreover, helminth infection through the modulation of the immune response might contribute to the high prevalence of diseases like cancer, HIV, and other viral diseases. Most cancers and HIV need a type-1 immune response, which is a kind of inflammation by having increased inflammatory cytokines [8, 18], whereas helminth infections induce a strong type-2 immune response, anti-inflammatory. This helminth-induced type-2 immune response could suppress the protective immune response against cancer and makes the immune response not quite intact with the alteration and reduction of micronutrients in human physiology and in immune cells [19, 20].

In our study, from the included participants, the highest group of cancer patients was found in stage 3 with a proportion of 20/41(48.7%)), and there was an overall intestinal helminth prevalence of 17%. With having a poor system of early detection of cancer in the community and health facilities in third world countries, having a chronic helminth infection might have a great impact on the progression of cancer to make it worsen. This is supported by a study that showed that infection can increase the progression of cancer and the development of carcinogenesis [21].

In our study, the prevalence of Ascaris lumbricoides and hookworm was 7.3% for each helminth, which is lower than a study done in Brazil that found that the overall helminth infection was 66.6% and Ascaris lumbricoides prevalence was 33.3% [22]. In contrast, a study done in Iran showed that the total helminth prevalence in cancer patients was 6.5% and the prevalence of Ascaris lumbricoides was 0.5% which is lower than our results, but the prevalence of Hymenolepis nana was 2.7% which is similar with our study [23]. On the other hand, the prevalence of Hymenolepis nana in our study is higher than a study done in Egypt 0.8% [24].

A study done in Malaysian children with cancer showed that the total helminth prevalence was 42% and the Ascaris lumbricoides prevalence was 22% and for Trichuris trichiura was 24% prevalence [25]. It is higher than the findings in our study. The difference might be due to the age group of the participants in which their study is exclusively on children, which will have a more frequent contact with soil and make them highly infected by soil-transmitted helminths.

In our study area, the total prevalence of helminth parasites in cancer patients was lower than that of HIV patients (29.1% (65/223)) [26], diabetes mellitus (DM) patients (19.2% (45/234)) [27], and in community-based study (24.2%) [28]. In this study, Ascaris lumbricoides infection was the highest in all cancer, HIV, and diabetes mellitus patients. Ascariasis, trichuriasis, and hookworm disease are all transmitted via soil and other means that are contaminated with excreta containing infective eggs or larvae. Transmission may occur near home or in a communal area with inadequate sanitation facilities and that is polluted with faeces [29].

5. Conclusions and Recommendations

Even if the data has a limitation on the sample size, the prevalence of intestinal helminths in cancer patients is lower than in HIV, DM, and in the community. However, the prevalence is still high. It is better to deworm these patients in every year, and there should be a proper consultation to have good personal and environmental hygiene than the health individual, and they need special attention for early detection of infectious disease.

Abbreviations

AML:	Acute myeloid leukemia
BMI:	Body mass index
DM:	Diabetes mellitus
kg/m²:	Kilograms per meter squared
g/dl:	Gram per deciliter
HIV:	Human immunodeficiency virus
HBV:	Hepatitis B virus.

Data Availability

All the data that support the findings in this study found in the corresponding author upon request.

Conflicts of Interest

All authors declare that there is no conflict of interest.

Authors’ Contributions

ML and ES were responsible for the developing of the idea and writing the proposal. ML, YA, and AS participate in patient recruitment and sample collection and preparation. ML and ES participated in stool sample analysis and reporting. ML and ES contributed to the analysis and interpretation of data and manuscript development.

Acknowledgments

We would like to acknowledge the study participants who participated in the study. We thank the laboratories of the University of Gondar College of Medicine and Health Science, Department of Internal Medicine, School of Biomedical and Laboratory Science, Department of Medical Parasitology, and Department of Immunology and Molecular Biology for supporting this project and oncology clinic for accepting the ethical issue and facilitating all necessary things. We would like to thank the staffs of the oncology clinic for preparing the patients and their medical record sheets.

References

J. A. Olanipekun and J. O. Babatunde, “Towards reducing the burden of global environmental related health problems in the 21st century,” Journal of Education and Practice, vol. 7, no. 32, pp. 57–64, 2016.
View at: Google Scholar
I. D. Amoah, P. Reddy, and T. A. Stenström, “Effect of reagents used during detection and quantification of Ascaris suum in environmental samples on egg viability,” Water Science and Technology, vol. 76, no. 9, pp. 2389–2400, 2017.
View at: Publisher Site | Google Scholar
H. Sung, J. Ferlay, R. L. Siegel et al., “Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries,” CA: a cancer journal for clinicians, vol. 71, no. 3, pp. 209–249, 2021.
View at: Publisher Site | Google Scholar
A. Degarege and B. Erko, “Association between intestinal helminth infections and underweight among school children in Tikur Wuha elementary school, northwestern Ethiopia,” Journal of Infection and Public Health, vol. 6, no. 2, pp. 125–133, 2013.
View at: Publisher Site | Google Scholar
I. M. Cattadori, A. Sebastian, H. Hao et al., “Impact of helminth infections and nutritional constraints on the small intestine microbiota,” PLoS One, vol. 11, no. 7, article e0159770, 2016.
View at: Publisher Site | Google Scholar
D. Voehringer, K. Shinkai, and R. M. Locksley, “Type 2 immunity reflects the orchestrated recruitment of cells committed to IL-4 production,” Immunity, vol. 20, no. 3, pp. 267–277, 2004.
View at: Publisher Site | Google Scholar
A. A. Hamid, M. Hasanain, A. Singh et al., “Synthesis of novel anticancer agents through opening of spiroacetal ring of diosgenin,” Steroids, vol. 87, pp. 108–118, 2014.
View at: Publisher Site | Google Scholar
T. L. Whiteside, “Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention,” Seminars in cancer biology, Elsevier, vol. 16, no. 1, pp. 3–15, 2006.
View at: Publisher Site | Google Scholar
M. Agholi, G. R. Hatam, and M. H. Motazedian, “HIV/AIDS-associated opportunistic protozoal diarrhea,” AIDS research and human retroviruses, vol. 29, no. 1, pp. 35–41, 2013.
View at: Publisher Site | Google Scholar
Z. T. Mariam, G. Abebe, and A. Mulu, “Opportunistic and Other Intestinal Parasitic Infections in AIDS Patients, HIV Seropositive Healthy Carriers, and HIV Seronegative Individuals in Southwest Ethiopia,” East African Journal of Public Health, vol. 5, no. 3, pp. 169–173, 2008.
View at: Google Scholar
A. Missaye, M. Dagnew, A. Alemu, and A. Alemu, “Prevalence of intestinal parasites and associated risk factors among HIV/AIDS patients with pre-ART and on-ART attending dessie hospital ART clinic, Northeast Ethiopia,” Northeast Ethiopia. AIDS research and therapy, vol. 10, no. 1, pp. 1–9, 2013.
View at: Publisher Site | Google Scholar
H. Adamu, T. Wegayehu, and B. Petros, “High prevalence of diarrhoegenic intestinal parasite infections among non-ART HIV patients in Fitche hospital, Ethiopia,” PLoS One, vol. 8, no. 8, article e72634, 2013.
View at: Publisher Site | Google Scholar
D. Elias, G. Mengistu, H. Akuffo, and S. Britton, “Are intestinal helminths risk factors for developing active tuberculosis?” Tropical Medicine & International Health, vol. 11, no. 4, pp. 551–558, 2006.
View at: Publisher Site | Google Scholar
S. Lustigman, R. K. Prichard, A. Gazzinelli et al., “A research agenda for helminth diseases of humans: the problem of helminthiases,” PLoS Neglected Tropical Diseases, vol. 6, no. 4, article e1582, 2012.
View at: Publisher Site | Google Scholar
D. W. T. Crompton and M. C. Nesheim, “Nutritional impact of intestinal helminthiasis during the human life cycle,” Annual review of nutrition, vol. 22, no. 1, pp. 35–59, 2002.
View at: Publisher Site | Google Scholar
F. Jalal, M. Nesheim, Z. Agus, D. Sanjur, and J. Habicht, “Serum retinol concentrations in children are affected by food sources of beta-carotene, fat intake, and anthelmintic drug treatment,” The American Journal of Clinical Nutrition, vol. 68, no. 3, pp. 623–629, 1998.
View at: Publisher Site | Google Scholar
A. Tomkins and F. Watson, “Malnutrition and infection: a review,” ACC/SCN State-of-the-Art Series, Nutrition Policy Discussion Paper (UN/ACC), no. 5, 1989.
View at: Google Scholar
C. Andrews and R. Koup, “The Immunopathology of HIV infection,” Journal of Antimicrobial Chemotherapy, vol. 37, supplement B, pp. 13–25, 1996.
View at: Publisher Site | Google Scholar
R. S. Goldszmid, A. Dzutsev, and G. Trinchieri, “Host immune response to infection and cancer: unexpected commonalities,” Cell host & microbe, vol. 15, no. 3, pp. 295–305, 2014.
View at: Publisher Site | Google Scholar
T. L. Whiteside, “Immune responses to malignancies,” Journal of Allergy and Clinical Immunology, vol. 125, no. 2, pp. S272–S283, 2010.
View at: Publisher Site | Google Scholar
C. Jacqueline, A. Tasiemski, G. Sorci et al., “Infections and cancer: the “Fifty shades of immunity” hypothesis,” BMC Cancer, vol. 17, no. 1, pp. 1–11, 2017.
View at: Publisher Site | Google Scholar
S. Jeske, T. Bianchi, M. Moura et al., “Intestinal parasites in cancer patients in the South of Brazil,” Brazilian Journal of Biology, vol. 78, no. 3, pp. 574–578, 2018.
View at: Publisher Site | Google Scholar
N. Y. H. Pestechian, F. Mokarian, M. J. Tarahi, A. Sepahvand, and S. Tavakoli, “Prevalence of parasitic infections in cancer patients and healthy individuals in cancer patients and healthy individuals in Isfahan, Iran during a 5-year investigation,” Journal of Cancer Research Forecast, vol. 3, 2020.
View at: Google Scholar
A. A. Abdel-Magied, W. A. El-Ghanam, H. I. El-Nemr, and A. A. El-Henawy, “Prevalence of intestinal parasites in cancer therapy recipients with concurrent diarrhea,” International Journal of TROPICAL DISEASE & Health, vol. 15, no. 1, pp. 1–7, 2016.
View at: Publisher Site | Google Scholar
B. S. Menon, M. S. Abdullah, F. Mahamud, and B. Singh, “Brief report. Intestinal parasites in Malaysian children with cancer,” Journal of Tropical Pediatrics, vol. 45, no. 4, pp. 241-242, 1999.
View at: Publisher Site | Google Scholar
T. Eshetu, G. Sibhatu, M. Megiso et al., “Intestinal parasitosis and their associated factors among people living with HIV at University of Gondar Hospital, Northwest-Ethiopia,” Ethiopian Journal of Health Sciences, vol. 27, no. 4, pp. 411–420, 2017.
View at: Publisher Site | Google Scholar
S. Ambachew, M. Assefa, Y. Tegegne, and A. J. Zeleke, “The prevalence of intestinal parasites and their associated factors among diabetes mellitus patients at the University of Gondar Referral Hospital, Northwest Ethiopia,” Journal of Parasitology Research, vol. 2020, Article ID 8855965, 6 pages, 2020.
View at: Publisher Site | Google Scholar
J. D. King, T. Endeshaw, E. Escher et al., “Intestinal parasite prevalence in an area of Ethiopia after implementing the SAFE strategy, enhanced outreach services, and health extension program,” PLoS neglected tropical diseases, vol. 7, no. 6, article e2223, 2013.
View at: Publisher Site | Google Scholar
A. Prüss-Üstün, J. Wolf, C. Corvalán, R. Bos, and M. Neira, Preventing disease through healthy environments: a global assessment of the burden of disease from environmental risks: world health, World Health Organization, 2016.

Copyright

Copyright © 2022 Elsa Sitotaw et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1442

Downloads

1217

Citations